Zealand Pharma A/S (ZLDPF)

Zealand Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	480.3	449.31	1,069	1,129	960.22
Short-Term Investments	23.63	-	-	-	-
Trading Asset Securities	7,722	1,184	108.61	299.04	297.35
Cash & Short-Term Investments	8,226	1,633	1,178	1,428	1,258
Cash Growth	403.72%	38.65%	-17.53%	13.56%	-8.91%
Accounts Receivable	193.56	97.8	115.62	153.45	46.48
Other Receivables	97.44	40.99	21.6	21.56	15.44
Receivables	291	138.8	137.22	175.02	61.93
Inventory	10.7	7.94	1.29	118.44	65.04
Prepaid Expenses	-	-	-	-	35.16
Total Current Assets	8,528	1,780	1,316	1,722	1,420
Property, Plant & Equipment	125.25	149.85	165.49	221.45	213.04
Long-Term Investments	819.63	21.38	37.84	26.91	32.33
Other Intangible Assets	12.62	12.26	-	53.79	57.49
Long-Term Accounts Receivable	-	6.89	18.11	29.09	-
Long-Term Deferred Tax Assets	0.99	0.93	2.02	13.53	8.37
Other Long-Term Assets	19.41	8.91	-	1.27	31.04
Total Assets	9,506	1,980	1,540	2,068	1,762
Accounts Payable	181.28	91.61	180.76	266.39	70.38
Accrued Expenses	93.66	51.73	-	-	36.67
Current Portion of Leases	16.04	16.66	14.73	14.9	14.07
Current Income Taxes Payable	-	-	-	-	30.39
Current Unearned Revenue	-	-	-	53.03	53.18
Other Current Liabilities	112.5	124.59	-	-	150.56
Total Current Liabilities	403.47	284.58	195.49	334.32	355.26
Long-Term Debt	285.33	-	401.35	647.91	-
Long-Term Leases	90.39	102.58	108	124.63	116.05
Long-Term Unearned Revenue	-	-	-	14.55	44.59
Other Long-Term Liabilities	109.67	-	19.06	18.43	16.74
Total Liabilities	888.86	387.15	723.9	1,140	532.64
Common Stock	71.02	58.75	51.7	43.63	39.8
Additional Paid-In Capital	14,681	6,406	4,921	-	3,472
Retained Earnings	-6,157	-4,895	-4,172	-	-2,290
Treasury Stock	-	-	-	-	-1.7
Comprehensive Income & Other	22.39	22.7	14.62	884.17	8.98
Shareholders' Equity	8,617	1,593	815.91	927.8	1,229
Total Liabilities & Equity	9,506	1,980	1,540	2,068	1,762
Total Debt	391.76	119.23	524.08	787.43	130.12
Net Cash (Debt)	8,654	1,514	653.77	640.72	1,127
Net Cash Growth	471.66%	131.55%	2.04%	-43.17%	-12.92%
Net Cash Per Share	130.26	26.75	14.15	14.95	29.38
Filing Date Shares Outstanding	70.65	58.38	51.47	43.22	39.55
Total Common Shares Outstanding	70.65	58.38	51.47	43.22	39.74
Working Capital	8,124	1,495	1,121	1,387	1,064
Book Value Per Share	121.96	27.28	15.85	21.47	30.94
Tangible Book Value	8,604	1,581	815.91	874.01	1,172
Tangible Book Value Per Share	121.78	27.07	15.85	20.22	29.49
Buildings	-	-	-	-	34.1
Machinery	84.91	78.57	82.83	106.63	101.18
Construction In Progress	-	-	0.87	12.11	3.02
Leasehold Improvements	39.3	38.91	38.19	36.6	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.